LXRX
NASDAQ · Pharmaceuticals
Lexicon Pharmaceuticals Inc
$2.47
+0.11 (+4.66%)
Open$2.44
Previous Close$2.36
Day High$2.48
Day Low$2.29
52W High$2.68
52W Low$1.02
Volume—
Avg Volume2.99M
Market Cap1.04B
P/E Ratio—
EPS$-0.07
SectorPharmaceuticals
Analyst Ratings
Buy
11 analysts
Price Target
+627.5% upside
Current
$2.47
$2.47
Target
$17.97
$17.97
$15.16
$17.97 avg
$22.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 62.00M | 68.34M | 62.90M |
| Net Income | -62,676,878 | 19.40M | 18.23M |
| Profit Margin | -101.1% | 28.4% | 29.0% |
| EBITDA | -60,101,116 | 29.54M | 28.34M |
| Free Cash Flow | — | 10.65M | 12.86M |
| Rev Growth | +692.7% | +10.7% | +9.3% |
| Debt/Equity | 0.50 | 0.92 | 0.73 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |